Gogoa Mobility Robots is a Basque Med-Tech biotechnology company dedicated to the design and development of high-tech robotic exoskeletons to improve people’s quality of life. As part of its commitment to excellence, Gogoa has its own robotic neuro-rehabilitation clinics, called Movex Clinics, as well as a laboratory for the design of personalised therapies. Our mission is to lead the revolution in the fields of rehabilitation and ergonomics, with the aim of increasing human capabilities and improving people’s well-being. We are also proud to be the first European company to obtain CE marking for the HANK exoskeleton for lower limb rehabilitation.
At Gogoa, we use this creative vision together with the Design Thinking methodology in every step we take. We seek a balance between the theory of science and the real connection of human beings with the environment around them.
Our philosophy is one of wellbeing. We believe in improving the quality of life and in a better future.
The use of biomechanical exoskeletons in neuro-rehabilitation medical practices is rapidly gaining popularity. Our exoskeletons provide support and assistance to people with physical disabilities, enabling them to move more easily and efficiently. They can be used to help people with spinal cord injury, cerebral palsy, stroke and other physical disabilities regain their mobility and increase their strength and endurance. Exoskeletons can also be used to help people with limited mobility perform physiotherapy and rehabilitation exercises.
We are the first EUROPEAN company to obtain CE marking for a rehabilitation exoskeleton for lower limbs.
HANK: The most technologically advanced lower limb exoskeleton. The only one in the world with all 6 motorised joints and an adaptive gait pattern.
1. Our Movex Living Lab rehabilitation center will host an open house event where the public can witness the world’s first research center dedicated to designing rehab therapies using exoskeletons. Attendees will have the opportunity to see our exoskeletons in action with real patients, and learn how this technology can aid in the recovery process for individuals with mobility impairments.
2. We aim to share success stories of individuals who have benefited from using our exoskeletons, through various marketing channels such as social media, blog posts, and other promotional materials. Our goal is to increase awareness of this technology and its potential to improve the quality of life for people with mobility impairments.
